What do systematic reviews say?

Summary of Findings Table ‐ Electrocoagulation alone vs control (vehicle solution of allopurinol by mouth)

It is very uncertain whether summary of Findings Table ‐ Electrocoagulation alone changes all‐cause mortality at last compared with control (vehicle solution of allopurinol by mouth) (very low certainty).

• Electrocoagulation for liver metastases 2021 · Cochrane Headline outcomes only
  RR 0.98 [0.94, 1.03]
  1 study · 113 participants
  Very low

Summary of Findings Table ‐ Electrocoagulation alone vs control (vehicle solution of allopurinol by mouth)

It is very uncertain whether summary of Findings Table ‐ Electrocoagulation alone changes post‐operative deaths compared with control (vehicle solution of allopurinol by mouth) (very low certainty).

• Electrocoagulation for liver metastases 2021 · Cochrane Headline outcomes only
  RR 1.03 [0.07, 16.12]
  1 study · 152 participants
  Very low

Summary of Findings Table ‐ Electrocoagulation alone vs control (vehicle solution of allopurinol by mouth)

The review found no eligible studies for this question.

• Electrocoagulation for liver metastases 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of Findings Table ‐ Electrocoagulation alone vs control (vehicle solution of allopurinol by mouth)

The review found no eligible studies for this question.

• Electrocoagulation for liver metastases 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of Findings Table ‐ Electrocoagulation alone vs control (vehicle solution of allopurinol by mouth)

The review found no eligible studies for this question.

• Electrocoagulation for liver metastases 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

• Contrast‐enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease 2022 · Cochrane Headline outcomes only
  no estimate extracted
  23 studies · 6546 participants
  Very low

Intervention not reported

• Contrast‐enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease 2022 · Cochrane Headline outcomes only
  no estimate extracted
  13 studies · 1257 participants
  Low

Intervention not reported

• Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease 2022 · Cochrane Headline outcomes only
  no estimate extracted
  34 studies · 4841 participants
  Low

Intervention not reported

• Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease 2022 · Cochrane Headline outcomes only
  no estimate extracted
  16 studies · 2150 participants
  Low

Intervention not reported

• Abdominal ultrasound and alpha‐foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  147 studies · 52144 participants
  Very low

Intervention not reported

• Abdominal ultrasound and alpha‐foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  56 studies · 20452 participants
  Very low

Intervention not reported

• Abdominal ultrasound and alpha‐foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  39 studies · 18792 participants
  Very low

Intervention not reported

• Abdominal ultrasound and alpha‐foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 5044 participants
  Low

Intervention not reported

• Abdominal ultrasound and alpha‐foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 5044 participants
  Low

Intervention not reported

• Abdominal ultrasound and alpha‐foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 5044 participants
  Low

Intervention not reported

• Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease 2021 · Cochrane Headline outcomes only
  no estimate extracted
  21 studies · 3101 participants
  Low

Intervention not reported

• Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease 2021 · Cochrane Headline outcomes only
  no estimate extracted
  10 studies · 1854 participants
  Low

Intervention not reported

The review found no eligible studies for this question.

• Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma 2015 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

• Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma 2015 · Cochrane Headline outcomes only
  no estimate extracted
  185 participants
  Low

Intervention not reported

• Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma 2015 · Cochrane Headline outcomes only
  no estimate extracted
  185 participants
  Low